Page 234 - Genentech News Today

/PRNewswire/ -- DelveInsights Glioblastoma Multiforme Market Insights report includes a comprehensive understanding of current treatment practices,...

The glioblastoma multiforme market is expected to witness a significant positive shift owing to the positive outcomes of the several products during the developmental stage by key players such

GlobalData uncovers the leading innovators in peptide-based compositions for Alzheimer's Disease for the pharmaceutical industry.

Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of...

Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and...

AC Immune to Present Progress of Alzheimer’s Disease Programs targeting Abeta and Tau at the 15th CTAD Conference Next generation SupraAntigen® liposomal vaccine platform augments immunization against pathological targets of Alzheimer’s diseaseNew data on anti-phospho-Tau vaccines confirm safety...

/PRNewswire/ -- DelveInsights Seasonal Influenza Market Insights report includes a comprehensive understanding of current treatment practices, seasonal...

Next generation SupraAntigen liposomal vaccine platform augments immunization against pathological targets of Alzheimer's diseaseNew data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity

The seasonal influenza market size is anticipated to increase in the coming years owing to the launch of the emerging therapies and vaccines. The current pipeline of seasonal influenza consists

In a chilling move that's reminiscent of George Orwell's '1984,' WHO announced steps it's taking to change social ...